112 related articles for article (PubMed ID: 3001122)
1. Radioimmunoassay and enzyme-linked immunoassay of antibodies directed against lymphadenopathy-associated virus (LAV) proteins larger than the core protein (P24).
Neurath AR; Strick N; Lee YS; Nilsen T; Baker L; Sproul P; Rubinstein P; Taylor P; Stevens CE; Gold JW
J Virol Methods; 1985 Oct; 12(1-2):85-92. PubMed ID: 3001122
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
[TBL] [Abstract][Full Text] [Related]
3. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
4. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J
Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889
[TBL] [Abstract][Full Text] [Related]
6. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.
Barré-Sinoussi F; Mathur-Wagh U; Rey F; Brun-Vezinet F; Yancovitz SR; Rouzioux C; Montagnier L; Mildvan D; Chermann JC
JAMA; 1985 Mar 22-29; 253(12):1737-9. PubMed ID: 2983130
[TBL] [Abstract][Full Text] [Related]
7. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
[TBL] [Abstract][Full Text] [Related]
8. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
Abb J
AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
[TBL] [Abstract][Full Text] [Related]
9. Serological characterization of HTLV-III infection in AIDS and related disorders.
Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
[TBL] [Abstract][Full Text] [Related]
10. Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association.
Jaffe HW; Sarngadharan MG; DeVico AL; Bruch L; Getchell JP; Kalyanaraman VS; Haverkos HW; Stoneburner RL; Gallo RC; Curran JW
JAMA; 1985 Aug; 254(6):770-3. PubMed ID: 2989568
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.
Casey JM; Kim Y; Andersen PR; Watson KF; Fox JL; Devare SG
J Virol; 1985 Aug; 55(2):417-23. PubMed ID: 2410630
[TBL] [Abstract][Full Text] [Related]
12. Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan.
Tsuchie H; Kurimura T; Hinuma Y
J Infect; 1985 May; 10(3):272-6. PubMed ID: 2993425
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
Hunsmann G; Schneider J; Bayer H; Kurth R; Werner A; Brede HD; Erfle V; Mellert W; Brodt HR; Bergmann L
Klin Wochenschr; 1985 Mar; 63(5):233-5. PubMed ID: 2985862
[TBL] [Abstract][Full Text] [Related]
14. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families.
Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR
Infection; 1986; 14(2):60-3. PubMed ID: 3011677
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy.
Goudsmit J; Lange JM; Krone WJ; Teunissen MB; Epstein LG; Danner SA; van den Berg H; Breederveld C; Smit L; Bakker M
J Virol Methods; 1987 Aug; 17(1-2):19-34. PubMed ID: 3478346
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III).
Abb J
Vox Sang; 1986; 51(3):233-5. PubMed ID: 3544497
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
[TBL] [Abstract][Full Text] [Related]
18. Bovine leukemia virus-related antigens in lymphocyte cultures infected with AIDS-associated viruses.
Thiry L; Sprecher-Goldberger S; Jacquemin P; Cogniaux J; Burny A; Bruck C; Portetelle D; Cran S; Clumeck N
Science; 1985 Mar; 227(4693):1482-4. PubMed ID: 2579433
[TBL] [Abstract][Full Text] [Related]
19. [LAV/HTLV-III antibodies in blood and blood products].
Gürtler L; Eberle J; Deinhardt F
Dtsch Med Wochenschr; 1985 Oct; 110(43):1639-40. PubMed ID: 2994977
[No Abstract] [Full Text] [Related]
20. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.
Lange JM; Coutinho RA; Krone WJ; Verdonck LF; Danner SA; van der Noordaa J; Goudsmit J
Br Med J (Clin Res Ed); 1986 Jan; 292(6515):228-30. PubMed ID: 3004634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
